A nationally representative analysis of "twin epidemics": Rising rates of methamphetamine use among persons who use opioids
A nationally representative analysis of "twin epidemics": Rising rates of methamphetamine use among persons who use opioids
复制标题
DOI：
10.1016/j.drugalcdep.2019.107592
复制
发表时间：
2019-11-01
影响因子：
4.2
通讯作者：
Stoops, William W.
中科院分区：
文献类型：
--
作者：
Strickland, Justin C.;Havens, Jennifer R.;Stoops, William W.
背景：最近的数据表明，甲基苯丙胺的效力、可负担性和可获得性在美国有所增加。其他数据表明，在寻求阿片类药物使用障碍治疗的患者中，甲基苯丙胺的使用率正在上升。在治疗范围之外的人群和报告使用其他物质的人群中，甲基苯丙胺使用的类似增加在多大程度上是未知的。目的：目前的分析使用具有全国代表性的数据源，根据阿片类药物使用历史评估过去一个月甲基苯丙胺使用的最新趋势。方法分析2015-2017年全国药物使用与健康调查（NSDUH）数据，按阿片类药物使用史分析过去一个月甲基苯丙胺使用的年度变化。敏感性分析评估了这些趋势是否特定于甲基苯丙胺使用和报告使用阿片类药物的人。结果：在报告过去一个月海洛因使用、过去一年海洛因使用障碍和过去一年处方阿片类药物使用障碍的人群中，过去一个月甲基苯丙胺使用显著增加。例如，在报告过去一个月使用海洛因的个人中，甲基苯丙胺的使用量从2015年的9.0%增加到2017年的30.2%，增长了两倍。这些关联是甲基苯丙胺特有的，其他物质的使用几乎没有变化。除处方镇定剂外，在报告使用其他非法药物的人群中，没有观察到甲基苯丙胺使用的类似增加。结论：这些结果提供了与美国甲基苯丙胺使用相关的紧急关注的确凿证据的数据。这些发现强调了考虑药物使用的全球驱动因素的重要性，以避免新的和正在出现的药物使用危机的循环浪潮。
Background: Recent data suggest increases in methamphetamine potency, affordability, and availability in the US. Other data indicate rising rates of methamphetamine use among patients seeking treatment for opioid use disorder. The extent to which similar increases in methamphetamine use have occurred for populations outside of a treatment context and for those reporting other substance use is unknown.Purpose: The current analysis used a nationally representative data source to evaluate recent trends in past month methamphetamine use based on opioid use history.Methods" Data from the 2015-2017 National Survey on Drug Use and Health (NSDUH) were analyzed for yearly variations in past month methamphetamine use by opioid use history. Sensitivity analyses assessed if these trends were specific to methamphetamine use and to persons reporting opioid use.Results: Significant increases in past month methamphetamine use were observed for persons reporting past month heroin use, past year heroin use disorder, and past year prescription opioid use disorder. Among individuals reporting past month heroin use, for example, methamphetamine use tripled from 9.0% in 2015 to 30.2% in 2017. These associations were specific to methamphetamine with little change in other substance use. Similar increases in methamphetamine use were not observed for populations reporting other illicit substance use with the exception of prescription tranquilizers.Conclusions: These results provide data corroborating evidence of emergent concerns related to methamphetamine use in the US. Such findings highlight the importance of considering global drivers of substance use to avoid cyclic waves of new and emerging substance use crises.